News and Announcements
Imugene Limited Raised $3.0m from Options Plan
- Published April 06, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Imugene Limited (ASX:IMU), an immune-oncology company is pleased to announce that it has raised approximately $3.0m as part of the Company’s option plan which expired on 31st March 2017.
KEY TAKEAWAYS:
- The price for shares exercised under the option plan was 1.5 cents per share.
- The unlisted options are to be issued in recognition of the additional services he has performed which has been deemed far in excess of the usual services of a Non-Executive Director of a company with Imugene’s positioning together with additional services Dr. Axel Hoos continues to provide.
IMU’s CEO, Leslie Chong said today “we are pleased with the outcome of the options plan which further places Imugene in a solid position to continue the development of our Her-2 focused clinical candidate, HER-Vaxx, plus our broader mimotope platform and arginine modulator program.”
The Company are also delighted that three prominent existing shareholders, Private Portfolio Managers, Platinum Asset Management and Celtic Capital, have increased their investment in Imugene via their roles as underwriters to the plan,” said Ms Chong.
Company Updates
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Backed By Leading Investment Groups and Family Offices
